乌司他丁联合连续性血液净化治疗重症急性胰腺炎分析
|
摘要
目的探讨乌司他丁联合连续性血液净化治疗重症急性胰腺炎(SAP)的效果。方法随机将我院2017年1月—2018年1月收治的86例SAP患者分为两组,每组43例。对照组给予乌司他丁,观察组在对照组的基础上行连续性血液净化。比较两组临床疗效。结果观察组总有效率、APACHE-Ⅱ评分及住院时间等均优于对照组(P <0.05)。结论乌司他丁联合连续性血液净化治疗SAP效果理想,有利于患者病情的快速康复。
Objective To investigate the effect of ulinastatin combined with continuous blood purification on severe acute pancreatitis(SAP). Methods 86 patients with SAP admitted to our hospital from January 2017 to January 2018 were randomly divided into two groups, 43 in each group. The control group was given ulinastatin, and the observation group was on the basis of continuous blood purification in the control group. The clinical efficacy of the two groups was compared. Results The total effective rate, APACHEII score and hospitalization time of the observation group were significantly better than the control group(P < 0.05). Conclusion Ulinastatin combined with continuous blood purification is effective in treating SAP, and facilitate the rapid recovery of patients' condition.
Objective To investigate the effect of ulinastatin combined with continuous blood purification on severe acute pancreatitis(SAP). Methods 86 patients with SAP admitted to our hospital from January 2017 to January 2018 were randomly divided into two groups, 43 in each group. The control group was given ulinastatin, and the observation group was on the basis of continuous blood purification in the control group. The clinical efficacy of the two groups was compared. Results The total effective rate, APACHEII score and hospitalization time of the observation group were significantly better than the control group(P < 0.05). Conclusion Ulinastatin combined with continuous blood purification is effective in treating SAP, and facilitate the rapid recovery of patients' condition.
引文
[1]徐彦立.联合血液净化治疗对重症急性胰腺炎患者炎症因子和疗效的影响[J].重庆医学,2015,44(18):2553-2556.
[2]朱冉.乌司他丁联合连续性静脉-静脉血液过滤对重症急性胰腺炎患者近期疗效和血清炎症反应的影响[J].社区医学杂志,2016,14(10):41-43.
[3]王宇辉,叶八宁.用乌司他丁腹腔灌洗疗法对重症急性胰腺炎患者进行治疗的效果分析[J].当代医药论丛,2015,13(17):228-230.
[4]段宏军,安媛,王峰,等.血液滤过联合乌司他丁治疗重症急性胰腺炎的疗效观察[J].河北医药,2015,37(20):3089-3091.
[5]陈润奇.乌司他丁对重症急性胰腺炎患者支气管肺泡灌洗可溶性髓样细胞触发受体1的影响[J].临床和实验医学杂志,2015,14(22):1867-1870.
[6]尹康,朱宏泉,许庆林.连续性血液净化对重症急性胰腺炎血浆炎症因子的影响分析[J].中国当代医药,2014,21(6):37-39.
[7]孙兴龙,鲁晓燕,孟静.乌司他丁治疗急性重症胰腺炎效果及对IL-6、CRP和免疫球蛋白的影响[J].现代消化及介入诊疗,2015,20(6):629-631.
[8]杨学华.乌司他丁与连续性血液净化联合治疗重症急性胰腺炎的临床疗效[J].实用医技杂志,2017,24(1):88-90.
[9]杨业龙.连续性血液净化治疗重症脓毒血症的临床效果观察[J].基层医学论坛,2016,20(36):5093-5094.
[10]陈剑,陶晓根.连续性血液净化对重症急性胰腺炎免疫功能及内环境稳态的影响[J].肝胆外科杂志,2014,22(6):427-430.
[11]姬长卫.探究连续性血液净化对重症胰腺炎患者的临床疗效及护理措施[J].中国继续医学教育,2017,9(25):121-123.
[12]魏威,武晓萌,李龙,等.乌司他丁联合连续性血液净化治疗重症急性胰腺炎的临床疗效分析[J].中国医药科学,2017,7(9):69-71.
[13]刘刚.乌司他丁治疗急性胰腺炎60例临床分析[J].中国卫生标准管理,2018,9(4):64-65.
[2]朱冉.乌司他丁联合连续性静脉-静脉血液过滤对重症急性胰腺炎患者近期疗效和血清炎症反应的影响[J].社区医学杂志,2016,14(10):41-43.
[3]王宇辉,叶八宁.用乌司他丁腹腔灌洗疗法对重症急性胰腺炎患者进行治疗的效果分析[J].当代医药论丛,2015,13(17):228-230.
[4]段宏军,安媛,王峰,等.血液滤过联合乌司他丁治疗重症急性胰腺炎的疗效观察[J].河北医药,2015,37(20):3089-3091.
[5]陈润奇.乌司他丁对重症急性胰腺炎患者支气管肺泡灌洗可溶性髓样细胞触发受体1的影响[J].临床和实验医学杂志,2015,14(22):1867-1870.
[6]尹康,朱宏泉,许庆林.连续性血液净化对重症急性胰腺炎血浆炎症因子的影响分析[J].中国当代医药,2014,21(6):37-39.
[7]孙兴龙,鲁晓燕,孟静.乌司他丁治疗急性重症胰腺炎效果及对IL-6、CRP和免疫球蛋白的影响[J].现代消化及介入诊疗,2015,20(6):629-631.
[8]杨学华.乌司他丁与连续性血液净化联合治疗重症急性胰腺炎的临床疗效[J].实用医技杂志,2017,24(1):88-90.
[9]杨业龙.连续性血液净化治疗重症脓毒血症的临床效果观察[J].基层医学论坛,2016,20(36):5093-5094.
[10]陈剑,陶晓根.连续性血液净化对重症急性胰腺炎免疫功能及内环境稳态的影响[J].肝胆外科杂志,2014,22(6):427-430.
[11]姬长卫.探究连续性血液净化对重症胰腺炎患者的临床疗效及护理措施[J].中国继续医学教育,2017,9(25):121-123.
[12]魏威,武晓萌,李龙,等.乌司他丁联合连续性血液净化治疗重症急性胰腺炎的临床疗效分析[J].中国医药科学,2017,7(9):69-71.
[13]刘刚.乌司他丁治疗急性胰腺炎60例临床分析[J].中国卫生标准管理,2018,9(4):64-65.